Tissue-type plasminogen activator as a therapeutic target in stroke.

Expert Opinion on Therapeutic Targets
Iordanis Gravanis, Stella E Tsirka

Abstract

Ischemic stroke is a leading cause of morbidity and mortality worldwide and recombinant human tissue-type plasminogen activator (tPA) is the prominent therapeutic among very few therapeutics used in its treatment. Due to complications attributed to the drug, most notably transformation of ischemia to hemorrhage, tPA is only used in a small number of ischemic stroke cases, albeit significantly more often in specialized stroke centers. What are the mechanisms of tPA action and side effects in ischemic stroke, and can the knowledge about these mechanisms aid in making tPA a more efficacious and safe therapeutic or in developing alternative therapeutics? tPA use and alternative/combination therapies in acute ischemic stroke treatment are summarized. The review focuses on literature concerning tPA neurotoxicity and its implications for further development of tPA as a stroke therapeutic. Exogenously administered recombinant tPA and endogenous tPA have both turned into promising therapeutic targets for the stroke patient.

References

Aug 15, 1992·Proceedings of the National Academy of Sciences of the United States of America·G BuA L Schwartz
Jan 1, 1986·Journal of Cellular Biochemistry·A J van ZonneveldH Pannekoek
Dec 14, 1995·The New England Journal of Medicine·UNKNOWN National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group
Jul 18, 1996·The New England Journal of Medicine·UNKNOWN Multicenter Acute Stroke Trial--Europe Study GroupJ P Boissel
Nov 14, 1996·Nature·S E TsirkaS Strickland
Dec 22, 1999·Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism·W MengE H Lo
Jan 5, 2000·Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism·Q JiangM Chopp
Feb 22, 2000·Hormone Research·R Z Klein, M L Mitchell
Mar 4, 2000·Stroke; a Journal of Cerebral Circulation·UNKNOWN Abciximab in Ischemic Stroke Investigators
Feb 27, 2001·Journal of Neuroscience Research·M P Flavin, G Zhao

❮ Previous
Next ❯

Citations

Sep 10, 2009·Antioxidants & Redox Signaling·Sarah K HartenPatrick H Maxwell
Jan 14, 2010·Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism·Haihao ZhuXiaoying Wang
Aug 14, 2008·Protein Science : a Publication of the Protein Society·Hyesook YoonMichael Blaber
Jul 23, 2011·Developmental Neurobiology·Kim M Baeten, Katerina Akassoglou
Dec 6, 2014·Frontiers in Cellular Neuroscience·Hyun Ah KimChristopher G Sobey
Nov 7, 2015·PloS One·Yunfeng ZhangJianping Jia
Aug 23, 2016·Expert Opinion on Biological Therapy·Aldo BonaventuraFranco Dallegri
Oct 14, 2016·Journal of Stroke·Jongseong KimDong-Eog Kim
Jun 24, 2017·Expert Review of Neurotherapeutics·Georgios TsivgoulisAndrei V Alexandrov
Jul 25, 2017·Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism·Johannes KaesmacherTobias Boeckh-Behrens
Mar 15, 2018·Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism·Tauheed IshratSusan C Fagan
Dec 21, 2017·Oxidative Medicine and Cellular Longevity·Kiyoshi KikuchiIkuro Maruyama
Jan 26, 2018·Journal of Midwifery & Women's Health·Bethany D SandersJulia C Phillippi
Sep 19, 2019·Journal of Thrombosis and Haemostasis : JTH·Dante DisharoonKeith B Neeves
Mar 21, 2019·Current Pharmaceutical Design·Keita ShibataKoji Nobe
May 19, 2019·Neuromolecular Medicine·Saif AhmadAndrew F Ducruet
Feb 1, 2020·British Journal of Hospital Medicine·Arup SenAjay Bhalla
Sep 12, 2018·Proceedings of the National Academy of Sciences of the United States of America·Yuguo XiaJun Chen
Oct 28, 2018·Scientific Reports·Kiyoshi KikuchiSalunya Tancharoen
Nov 16, 2019·Biomaterials Science·Yao-Xing ChenXiao-Ling Gao
Jan 1, 2021·Expert Opinion on Pharmacotherapy·Adithya KannanE Sander Connolly
Nov 21, 2020·Journal of Controlled Release : Official Journal of the Controlled Release Society·Mohit Pratap SinghAshish Ranjan
Sep 22, 2019·Colloids and Surfaces. B, Biointerfaces·Deepak PradhanRakesh K Tekade
Jun 26, 2020·Molecular Pharmaceutics·Rebecca M KandellEster J Kwon
Aug 10, 2019·Progress in Neurobiology·Nadia PeyravianSylvia Daunert
Sep 15, 2018·Biochimica Et Biophysica Acta. Molecular Basis of Disease·Derek Barthels, Hiranmoy Das
May 14, 2021·Pharmaceutical Research·Pushkar SaralkarWerner J Geldenhuys
Jul 25, 2021·International Journal of Molecular Sciences·Eun-Hye KimOk-Nam Bae
Jul 29, 2021·Molecular Neurobiology·Elisabetta GeraceGuido Mannaioni

❮ Previous
Next ❯

Related Concepts

Related Feeds

Brain Ischemia

Brain ischemia is a condition in which there is insufficient blood flow to the brain to meet metabolic demand. Discover the latest research on brain ischemia here.